NeoTract, Inc., today announced that the Centers for Medicare and Medicaid Services (CMS) have issued two new codes that describe the UroLift® implant procedure for the treatment of enlarged prostate ...
The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX)– Men in France living with Benign Prostatic Hyperplasia (BPH), a condition in which the prostate enlarges as men get older and can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback